Publications

(2021). Review of Prognostic Expression Markers for Clear Cell Renal Cell Carcinoma. Frontiers in Oncology.

PDF DOI

(2020). B cells and cancer: To B or not to B?. Journal of Experimental Medicine.

DOI

(2020). The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies. Frontiers in Immunology.

PDF DOI

(2020). B cells and tertiary lymphoid structures promote immunotherapy response. Nature.

DOI

(2020). B cells are associated with survival and immunotherapy response in sarcoma. Nature.

DOI

(2019). Context-dependent roles of complement in cancer. Nature Reviews Cancer.

DOI

(2019). Recovery of central memory and naive peripheral T cells in Follicular Lymphoma patients receiving rituximab-chemotherapy based regimen. Scientific Reports.

DOI

(2019). Tumor Cells Hijack Macrophage-Produced Complement C1q to Promote Tumor Growth. Cancer Immunology Research.

DOI

(2019). Association of IL-36γ with tertiary lymphoid structures and inflammatory immune infiltrates in human colorectal cancer. Cancer Immunology, Immunotherapy.

DOI

(2018). Immune-based identification of cancer patients at high risk of progression. Current Opinion in Immunology.

DOI

(2017). Transcriptomic analysis of the tumor microenvironment to guide prognosis and immunotherapies. Cancer Immunology, Immunotherapy.

DOI

(2016). Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biology.

PDF DOI